Castellum, Inc. (NYSEAMERICAN:CTM – Get Free Report) was the target of a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 445,800 shares, a drop of 9.1% from the August 31st total of 490,400 shares. Based on an average daily volume of 1,340,000 shares, the days-to-cover ratio is presently 0.3 days. Approximately 1.5% of the shares of the stock are short sold.
Institutional Investors Weigh In On Castellum
An institutional investor recently raised its position in Castellum stock. Virtu Financial LLC grew its stake in Castellum, Inc. (NYSEAMERICAN:CTM – Free Report) by 82.2% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 103,288 shares of the company’s stock after acquiring an additional 46,606 shares during the period. Virtu Financial LLC owned about 0.19% of Castellum worth $27,000 as of its most recent filing with the SEC. 3.39% of the stock is currently owned by institutional investors.
Castellum Stock Performance
CTM traded down $0.01 on Tuesday, reaching $0.17. 37,030 shares of the company’s stock were exchanged, compared to its average volume of 565,111. The firm has a market capitalization of $9.40 million, a PE ratio of -0.50 and a beta of -3.33. Castellum has a twelve month low of $0.12 and a twelve month high of $0.60. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.66.
Castellum Company Profile
Castellum, Inc provides services in the areas of cybersecurity, information technology, electronic and information warfare, and information operations. Its services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model based systems engineering services.
See Also
- Five stocks we like better than Castellum
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Lennar Stock Could Be the Best Play in the Housing Market
- With Risk Tolerance, One Size Does Not Fit All
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What Are Growth Stocks and Investing in Them
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Castellum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castellum and related companies with MarketBeat.com's FREE daily email newsletter.